Publications of Elisabeth B. Binder
All genres
Journal Article (426)
261.
Journal Article
83 (2), pp. 344 - 360 (2014)
MicroRNA 135 Is Essential for Chronic Stress Resiliency, Antidepressant Efficacy, and Intact Serotonergic Activity. NEURON 262.
Journal Article
16 (3), pp. 395 - 404 (2014)
Epigenetic alterations in depression and antidepressant treatment. Dialogues in clinical neuroscience 263.
Journal Article
24 (1), pp. 5 - 50 (2014)
Stratified medicine for mental disorders. EUROPEAN NEUROPSYCHOPHARMACOLOGY 264.
Journal Article
13 (1), pp. 25 - 37 (2014)
Gene-environment interactions at the FKBP5 locus: sensitive periods, mechanisms and pleiotropism. GENES BRAIN AND BEHAVIOR 265.
Journal Article
123 (10), pp. 4158 - 4169 (2013)
Accelerated neurodegeneration through chaperone-mediated oligomerization of tau. JOURNAL OF CLINICAL INVESTIGATION 266.
Journal Article
18 (9), pp. 957 - 958 (2013)
Secreted frizzled-related protein 3 (sFRP3) regulates antidepressant responses in mice and humans. MOLECULAR PSYCHIATRY 267.
Journal Article
45 (9), pp. 984 - 994 (2013)
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. NATURE GENETICS 268.
Journal Article
43 (9), pp. 1965 - 1971 (2013)
Estimating the heritability of reporting stressful life events captured by common genetic variants. PSYCHOLOGICAL MEDICINE 269.
Journal Article
132 (9), pp. 1027 - 1037 (2013)
Epigenomic association analysis identifies smoking-related DNA methylation sites in African Americans. HUMAN GENETICS 270.
Journal Article
8 (7), e68645 (2013)
Functional Coding Variants in SLC6A15, a Possible Risk Gene for Major Depression. PLOS ONE 271.
Journal Article
23 (7), pp. 653 - 662 (2013)
Resistance to antidepressant treatment is associated with polymorphisms in the leptin gene, decreased leptin mRNA expression, and decreased leptin serum levels. EUROPEAN NEUROPSYCHOPHARMACOLOGY 272.
Journal Article
31, pp. 205 - 215 (2013)
Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression. BRAIN BEHAVIOR AND IMMUNITY 273.
Journal Article
5 (188), 188ra73 (2013)
Amygdala-Dependent Fear Is Regulated by Oprl1 in Mice and Humans with PTSD. SCIENCE TRANSLATIONAL MEDICINE 274.
Journal Article
110 (20), pp. 8302 - 8307 (2013)
Childhood maltreatment is associated with distinct genomic and epigenetic profiles in posttraumatic stress disorder. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 275.
Journal Article
7, 30 (2013)
Differential genetic and epigenetic regulation of catechol-O-methyltransferase is associated with impaired fear inhibition in posttraumatic stress disorder. FRONTIERS IN BEHAVIORAL NEUROSCIENCE 276.
Journal Article
70 (4), pp. 392 - 400 (2013)
FKBP5 and Attention Bias for Threat Associations With Hippocampal Function and Shape. JAMA PSYCHIATRY 277.
Journal Article
16 (3), pp. 701 - 711 (2013)
Gene x environment interactions in the prediction of response to antidepressant treatment. International Journal of Neuropsychopharmacology 278.
Journal Article
5 (2), pp. 109 - 112 (2013)
Allele-specific epigenetic modification: a molecular mechanism for gene-environment interactions in stress-related psychiatric disorders? [Editorial]. EPIGENOMICS 279.
Journal Article
58 (2), pp. 76 - 83 (2013)
Gene-Environment Interactions in Major Depressive Disorder. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE 280.
Journal Article
38 (1), pp. 84 - 93 (2013)
Glucocorticoid sensitizers Bag1 and Ppid are regulated by adolescent stress in a sex-dependent manner. PSYCHONEUROENDOCRINOLOGY